Episode 21 - Chris Haqq - CMO Elicio Therapeutics episode artwork

EPISODE · Oct 16, 2024 · 33 MIN

Episode 21 - Chris Haqq - CMO Elicio Therapeutics

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

Welcome back to another episode of The BioHub! Today, we’re thrilled to have Dr. Chris Haqq, Chief Medical Officer and Head of Research & Development at Elicio Therapeutics, join us. Chris is an expert in immuno-oncology with over 20 years of experience in the biotech industry. He has a remarkable track record in leading innovative therapies from concept to clinical stages, including his pivotal role in developing groundbreaking T cell therapies at Atara Biotherapeutics. In this episode, we’ll explore Elicio’s unique approach to cancer immunotherapy, Chris’s insights on the current biotech landscape, and what it takes to lead in such a challenging field.

NOW PLAYING

Episode 21 - Chris Haqq - CMO Elicio Therapeutics

0:00 33:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 33 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on October 16, 2024.

What is this episode about?

Welcome back to another episode of The BioHub! Today, we’re thrilled to have Dr. Chris Haqq, Chief Medical Officer and Head of Research & Development at Elicio Therapeutics, join us. Chris is an expert in immuno-oncology with over 20 years of...

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!